Letter to the Editor From Marin et al: “The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography”
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad170 ↗Kurz gefasst
Kommentar in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Loris Marin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, University of Padua, 35128, Padua, Italy. Hauptthemen laut MEDLINE: Iodine, Thyroid Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Women's and Children's Health, University of Padua, 35128, Padua, Italy.
- Department of Medicine-Endocrinology, University of Padua, 35128, Padua, Italy.
ORCID-Profile: Loris Marin
Zitieren
APA
Marin, L., Sabbadin, C., Armanini, D., Ambrosini, G., & Andrisani, A. (2023). Letter to the Editor From Marin et al: “The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography”. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad170
Vancouver
Marin L, Sabbadin C, Armanini D, Ambrosini G, Andrisani A. Letter to the Editor From Marin et al: “The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography”. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad170
BibTeX
@article{Marin2023,
author = {Marin, Loris and Sabbadin, Chiara and Armanini, Decio and Ambrosini, Guido and Andrisani, Alessandra},
title = {Letter to the Editor From Marin et al: “The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography”},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad170}
}
EUVIMED